GoldenGolden
Advanced Search

AgomAb (Company)

Agonistic monoclonal antibody molecules

All edits

Edits on 22 Jul, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 22 Jul, 2021
Edits made to:
Infobox (+3/-3 properties)
Infobox
Latest funding round date
April 2019
Latest funding type
Total funding amount (USD)
23,600,000
Latest funding round date
March 10, 2021
Latest funding type
Total funding amount (USD)
97,600,000
Golden AI
Golden AI edited on 22 Jul, 2021
Edits made to:
Infobox (+1 properties)
Edits on 4 Jun, 2021
Erin Scherfner"prospector:312:153949"
Erin Scherfner edited on 4 Jun, 2021
Edits made to:
Infobox (+2 properties)
Description (+39 characters)

AgomAb (Company)

Agonistic monoclonal antibody molecules

Infobox
Edits on 12 May, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 12 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Edits on 29 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+6 properties)
Infobox
Investors
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
April 2019
Edits on 26 Mar, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 26 Mar, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
23,600,000
Edits on 4 Aug, 2019
Golden AI
Golden AI edited on 4 Aug, 2019
Edits made to:
Infobox (+1 properties)
Golden AI
Golden AI edited on 4 Aug, 2019
Edits made to:
Infobox (+2 properties)
Infobox
Golden AI"Initial topic creation"
Golden AI created this topic on 4 Aug, 2019
Edits made to:

 AgomAb (Company)

Agonistic monoclonal antibody molecules

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.